{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:52:20Z","timestamp":1789714340997,"version":"4.0.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jbc.2024.107495","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T23:12:43Z","timestamp":1719270763000},"page":"107495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Structural and thermodynamic characterization of a highly amyloidogenic dimer of transthyretin involved in a severe cardiomyopathy"],"prefix":"10.1016","volume":"300","author":[{"given":"Lucas do Amaral","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila S.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ot\u00e1vio Augusto","family":"Leit\u00e3o dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia Oliveira","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Gabriel","family":"Cabral Fernandes Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia","family":"Waddington-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Lucas","family":"Palhano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Foguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107495_bib1","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/WNL.36.7.900","article-title":"Transthyretin: a choroid plexus-specific transport protein in human brain: the 1986 S. Weir Mitchell Award","volume":"36","author":"Herbert","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2024.107495_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fendo.2014.00245","article-title":"Tweaking the structure to radically change the function: the evolution of transthyretin from 5-hydroxyisourate hydrolase to triiodothyronine distributor to thyroxine distributor","volume":"5","author":"Richardson","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jbc.2024.107495_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1006\/jsbi.2000.4273","article-title":"Review: TTR amyloidosis\u2014structural features leading to protein aggregation and their implications on therapeutic strategies","volume":"130","author":"Damas","year":"2000","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.jbc.2024.107495_bib4","doi-asserted-by":"crossref","first-page":"15525","DOI":"10.1021\/bi051608t","article-title":"The pathway by which the tetrameric protein transthyretin dissociates","volume":"44","author":"Foss","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107495_bib5","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1107\/S0907444996003046","article-title":"Structures of human transthyretin complexed with thyroxine at 2.0 \u00c5 resolution and 3\u2019,5\u2019-dinitro- N -acetyl- L -thyronine at 2.2 \u00c5 resolution","volume":"52","author":"Wojtczak","year":"1996","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2024.107495_bib6","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.93.26.15051","article-title":"Inhibiting transthyretin amyloid fibril formation via protein stabilization","volume":"93","author":"Miroy","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107495_bib7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0968-0896(98)00130-8","article-title":"Discovering transthyretin amyloid fibril inhibitors by limited screening","volume":"6","author":"Baures","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jbc.2024.107495_bib8","doi-asserted-by":"crossref","first-page":"12956","DOI":"10.1073\/pnas.95.22.12956","article-title":"Inhibiting transthyretin conformational changes that lead to amyloid fibril formation","volume":"95","author":"Peterson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107495_bib9","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0968-0896(99)00066-8","article-title":"Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid","volume":"7","author":"Baures","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jbc.2024.107495_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-894X(98)00696-9","article-title":"Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors","volume":"9","author":"Oza","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2024.107495_bib11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/74082","article-title":"Rational design of potent human transthyretin amyloid disease inhibitors","volume":"7","author":"Sacchettini","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.jbc.2024.107495_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/jm010257n","article-title":"Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors","volume":"45","author":"Oza","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107495_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/156800705774322076","article-title":"Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses","volume":"4","author":"Almeida","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.jbc.2024.107495_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/01.LAB.0000059937.11023.1F","article-title":"Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology","volume":"83","author":"Sekijima","year":"2003","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jbc.2024.107495_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2012.04.013","article-title":"The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients","volume":"164","author":"Dungu","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jbc.2024.107495_bib16","first-page":"1321","article-title":"Familial amyloidotic polyneuropathies","volume":"196","author":"Vallat","year":"2012","journal-title":"Bull. Acad. Natl. Med."},{"key":"10.1016\/j.jbc.2024.107495_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0006-291X(88)90188-X","article-title":"Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin","volume":"154","author":"Cornwell","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2024.107495_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","article-title":"Amyloid nomenclature 2022: update, novel proteins, and recommendations by the international society of amyloidosis (ISA) nomenclature committee","volume":"29","author":"Buxbaum","year":"2022","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2024.107495_bib19","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jbc.2024.107495_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jbc.2024.107495_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/mus.26034","article-title":"Estimating the global prevalence of transthyretin familial amyloid polyneuropathy: ATTR-FAP Global Prevalence","volume":"57","author":"Schmidt","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jbc.2024.107495_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans","volume":"336","author":"Jacobson","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2024.107495_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1079589","article-title":"Prevention of transthyretin amyloid disease by changing protein misfolding energetics","volume":"299","author":"Hammarstr\u00f6m","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107495_bib24","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1021\/bi048838c","article-title":"Dimeric transthyretin variant assembles into spherical neurotoxins","volume":"44","author":"Matsubara","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107495_bib25","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/bi952501g","article-title":"The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid","volume":"35","author":"Lai","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107495_bib26","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1021\/bi00151a036","article-title":"Partial denaturation of transthyretin is sufficient for amyloid fibril formation in\u00a0vitro","volume":"31","author":"Colon","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107495_bib27","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1021\/bi049621l","article-title":"Transthyretin aggregation under partially denaturing conditions is a downhill polymerization","volume":"43","author":"Hurshman","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107495_bib28","doi-asserted-by":"crossref","first-page":"32943","DOI":"10.1074\/jbc.274.46.32943","article-title":"The tetrameric protein transthyretin dissociates to a non-native monomer in solution","volume":"274","author":"Quintas","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107495_bib29","doi-asserted-by":"crossref","first-page":"27207","DOI":"10.1074\/jbc.M101024200","article-title":"Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants","volume":"276","author":"Quintas","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107495_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ceb.2007.05.005","article-title":"Protein energetics in maturation of the early secretory pathway","volume":"19","author":"Wiseman","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107495_bib31","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1073\/pnas.97.12.6445","article-title":"The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state","volume":"97","author":"Ferr\u00e3o-Gonzales","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107495_bib32","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-2836(03)00368-1","article-title":"Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease","volume":"328","author":"Ferr\u00e3o-Gonzales","year":"2003","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107495_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1468-1331.2008.02429.x","article-title":"Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families","volume":"16","author":"Saporta","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jbc.2024.107495_bib34","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/bi201365r","volume":"50","author":"Azevedo","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107495_bib35","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2024.107495_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/13506129.2012.673183","article-title":"Regional differences and similarities of familial amyloidotic polyneuropathy (FAP) presentation in Brazil","volume":"19","author":"Cruz","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2024.107495_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/2ea264c2-d70c-4a2e-b877-c084dc3a49db","article-title":"Structure-based analysis of A19D, a variant of transthyretin involved in familial amyloid cardiomyopathy","volume":"8","author":"Ferreira","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.107495_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/srep44709","article-title":"Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation","volume":"7","author":"Sant\u2019Anna","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2024.107495_bib39","first-page":"703","article-title":"Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis","volume":"267","author":"Gonz\u00e1lez-Duarte","year":"2020","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jbc.2024.107495_bib40","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1074\/jbc.M807100200","article-title":"Trapping the monomer of a non-amyloidogenic variant of transthyretin","volume":"284","author":"Palhano","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107495_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0022-2836(92)90669-B","article-title":"Dissociation of a native dimer to a molten globule monomer","volume":"223","author":"Silva","year":"1992","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107495_bib42","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1074\/jbc.273.15.9050","article-title":"Characterization of a partially folded monomer of the DNA-binding domain of human papillomavirus E2 protein obtained at high pressure","volume":"273","author":"Foguel","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107495_bib43","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1021\/bi001822b","article-title":"The binding of bis-ANS to the isolated GroEL apical domain fragment induces the formation of a folding intermediate with increased hydrophobic surface not observed in tetradecameric GroEL","volume":"40","author":"Smoot","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107495_bib44","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2018.0244","article-title":"Lessons from pressure denaturation of proteins","volume":"15","author":"Roche","year":"2018","journal-title":"J.\u00a0R. Soc. Interf."},{"key":"10.1016\/j.jbc.2024.107495_bib45","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1021\/bi035623e","article-title":"Temperature-induced dissociation of protein aggregates: accessing the denatured state","volume":"42","author":"Meersman","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107495_bib46","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.bpj.2013.04.024","article-title":"Observation of solvent penetration during cold denaturation of E. coli phosphofructokinase-2","volume":"104","author":"Ram\u00edrez-Sarmiento","year":"2013","journal-title":"Biophys. J."},{"key":"10.1016\/j.jbc.2024.107495_bib47","doi-asserted-by":"crossref","first-page":"15863","DOI":"10.1016\/S0021-9258(18)71557-3","article-title":"Anomalous pressure dissociation of large protein aggregates. Lack of concentration dependence and irreversibility at extreme degrees of dissociation of extracellular hemoglobin","volume":"264","author":"Silva","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107495_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107495_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/labinvest.3700059","article-title":"Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants","volume":"84","author":"Miller","year":"2004","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jbc.2024.107495_bib50","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/cb100144v","article-title":"Retinol and retinol-binding protein stabilize transthyretin via formation of retinol transport complex","volume":"5","author":"Hyung","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107495_bib51","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107495_bib52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1055\/s-0043-1764412","article-title":"Brazilian consensus for diagnosis, management and treatment of hereditary transthyretin amyloidosis with peripheral neuropathy: second edition","volume":"81","author":"Pinto","year":"2023","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jbc.2024.107495_bib53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1751-7133.2012.00303.x","article-title":"Diflunisal for ATTR cardiac amyloidosis","volume":"18","author":"Casta\u00f1o","year":"2012","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/j.jbc.2024.107495_bib54","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1532-5415.2011.03868.x","article-title":"Transthyretin cardiac amyloidoses in older north Americans","volume":"60","author":"Dharmarajan","year":"2012","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.jbc.2024.107495_bib55","article-title":"Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity","volume":"7","author":"Sant\u2019Anna","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107495_bib56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0022-2836(78)90368-6","article-title":"Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 \u00c5","volume":"121","author":"Blake","year":"1978","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107495_bib57","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1006\/jmbi.2000.4078","article-title":"A\u00a0comparative analysis of 23 structures of the amyloidogenic protein transthyretin","volume":"302","author":"H\u00f6rnberg","year":"2000","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107495_bib58","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jmb.2008.07.029","article-title":"Structural insight into pH-induced conformational changes within the native human transthyretin tetramer","volume":"382","author":"Palaninathan","year":"2008","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107495_bib59","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/biom9120889","article-title":"Exploration of the misfolding mechanism of transthyretin monomer: insights from hybrid-resolution simulations and markov state model analysis","volume":"9","author":"Zhou","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jbc.2024.107495_bib60","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.bpj.2020.08.043","article-title":"Edge strand dissociation and conformational changes in transthyretin under amyloidogenic conditions","volume":"119","author":"Childers","year":"2020","journal-title":"Biophys. J."},{"key":"10.1016\/j.jbc.2024.107495_bib61","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1126\/science.1062245","article-title":"Trans -suppression of misfolding in an amyloid disease","volume":"293","author":"Hammarstr\u00f6m","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107495_bib62","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3233\/JAD-2010-1331","article-title":"Simple in\u00a0vitro assays to identify amyloid-\u03b2 aggregation blockers for alzheimer\u2019s disease therapy","volume":"19","author":"Guo","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.jbc.2024.107495_bib63","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.neuropharm.2007.11.010","article-title":"Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for \u03b1-synuclein fibrils in\u00a0vitro","volume":"54","author":"Hirohata","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jbc.2024.107495_bib64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1139\/cjpp-2015-0117","article-title":"Inhibition of islet amyloid polypeptide aggregation and associated cytotoxicity by nonsteroidal anti-inflammatory drugs","volume":"94","author":"Fortin","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107495_bib65","first-page":"S44","article-title":"A\u00a0new mutation on the transthyretin gene (Ser112 to Ile) causes an amyloid neuropathy with severe cardiac impairment","volume":"12","author":"De Lucia","year":"1993","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.jbc.2024.107495_bib66","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/prot.21252","article-title":"Destabilization of transthyretin by pathogenic mutations in the DE loop","volume":"66","author":"Takeuchi","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.jbc.2024.107495_bib67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/bi00673a014","article-title":"Negative cooperativity in the binding of thyroxine to human serum prealbumin","volume":"14","author":"Ferguson","year":"1975","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107495_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181019","article-title":"Evaluating the effect of mutations and ligand binding on transthyretin homotetramer dynamics","volume":"12","author":"Salda\u00f1o","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.107495_bib69","doi-asserted-by":"crossref","first-page":"E6428","DOI":"10.1073\/pnas.1802977115","article-title":"Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease","volume":"115","author":"Klimtchuk","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107495_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101039","article-title":"Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation","volume":"297","author":"Esperante","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107495_bib71","doi-asserted-by":"crossref","first-page":"17851","DOI":"10.1021\/bi981876+","article-title":"Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation","volume":"37","author":"Lashuel","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107495_bib72","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1107\/S0907444913015308","article-title":"Decision making in xia 2","volume":"69","author":"Winter","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2024.107495_bib73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pc.44.100193.000513","article-title":"Pressure stability of proteins","volume":"44","author":"Silva","year":"1993","journal-title":"Annu. Rev. Phys. Chem."},{"key":"10.1016\/j.jbc.2024.107495_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12154-009-0027-5","article-title":"Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils\u2014current status","volume":"3","author":"Groenning","year":"2010","journal-title":"J.\u00a0Chem. Biol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824019963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824019963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T11:35:42Z","timestamp":1728473742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824019963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0021925824019963"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107495","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural and thermodynamic characterization of a highly amyloidogenic dimer of transthyretin involved in a severe cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107495"}}